最新报道:According to Investing, iSpecimen Inc. (ISPC), a biospecimen procurement company, announced that it has been approached by several cryptocurrency firms offering investment opportunities. The company is planning to build a $200 million digital asset corpus, aiming to diversify its balance sheet and support growth initiatives through tokenized real-world assets and leading cryptocurrencies. iSpecimen is continuing parallel discussions to develop a financial plan based on the Solana blockchain. The company plans to purchase Solana (SOL) tokens, including locked Solana tokens with contractual transfer or vesting restrictions, through over-the-counter transactions with cryptocurrency institutions.